Opaleye Management Inc.

Avg. Two Year Performance

(2%) Avg. Purchase Return
(1%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return22%46%(2%)(1%)(2%)
Purchase Success Rate8 of 217 of 214 of 210 of 210 of 21
Average Sale Return0%0%0%0%0%
Sale Success Rate0 of 40 of 40 of 40 of 40 of 4

Transdel Pharmaceuticals, I...

Drugs » Biotechnology

10% Owner:

Holdings: 3.77M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Protara Therapeutics, Inc.

Drugs » Biotechnology

10% Owner:

Holdings: 2.69M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Tracon Pharmaceuticals, Inc.

Drugs » Biotechnology

10% Owner:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Eton Pharmaceuticals, Inc.

Other » Other

10% Owner:

Holdings: 2.38M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Ocular Therapeutix, Inc

Drugs » Biotechnology

:

Holdings: 4.92M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Tela Bio, Inc.

Other » Other

:

Holdings: 2.07M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--